Cargando…
Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study)
BACKGROUND: We hypothesized that the high-dose opioid requirement in patients carrying the rs4680-GG variant in the COMT gene encoding catechol-O-methyltransferase would be greater for patients taking morphine than for those taking oxycodone, thus providing a much-needed biomarker to inform opioid s...
Autores principales: | Matsuoka, Hiromichi, Tsurutani, Junji, Chiba, Yasutaka, Fujita, Yoshihiko, Sakai, Kiyohiro, Yoshida, Takeshi, Nakura, Miki, Sakamoto, Ryo, Makimura, Chihiro, Ohtake, Yoichi, Tanaka, Kaoru, Hayashi, Hidetoshi, Takeda, Masayuki, Okuno, Tatsuya, Takegawa, Naoki, Haratani, Koji, Koyama, Atsuko, Nishio, Kazuto, Nakagawa, Kazuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020805/ https://www.ncbi.nlm.nih.gov/pubmed/36426809 http://dx.doi.org/10.1093/oncolo/oyac233 |
Ejemplares similares
-
Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain
por: Fujita, Yoshihiko, et al.
Publicado: (2023) -
Expectation of a Decrease in Pain Affects the Prognosis of Pain in Cancer Patients: a Prospective Cohort Study of Response to Morphine
por: Matsuoka, Hiromichi, et al.
Publicado: (2017) -
Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study)
por: Matsuoka, Hiromichi, et al.
Publicado: (2017) -
Incidence of carnitine deficiency in patients with cancer pain: A pilot study
por: Sakai, Kiyohiro, et al.
Publicado: (2017) -
Gender differences in cancer-related distress in Japan: a retrospective observation study
por: Koyama, Atsuko, et al.
Publicado: (2016)